The global Diagnostic Nuclear Medicines market was valued at US$ 4722 million in 2023 and is anticipated to reach US$ 7534.8 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.

Diagnostic Nuclear Medicines Market

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.

This report aims to provide a comprehensive presentation of the global market for Diagnostic Nuclear Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Nuclear Medicines.

Report Scope

The Diagnostic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diagnostic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diagnostic Nuclear Medicines Market Report

Report Metric	Details
Report Name	Diagnostic Nuclear Medicines Market
Accounted market size in 2023	US$ 4722 million
Forecasted market size in 2030	US$ 7534.8 million
CAGR	6.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Tc-99m F-18 Other
Segment by Application	Oncology Cardiology Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostic Nuclear Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostic Nuclear Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Nuclear Medicines Market growing?

Ans: The Diagnostic Nuclear Medicines Market witnessing a CAGR of 6.9% during the forecast period 2024-2030.

What is the Diagnostic Nuclear Medicines Market size in 2030?

Ans: The Diagnostic Nuclear Medicines Market size in 2030 will be US$ 7534.8 million.

Who are the main players in the Diagnostic Nuclear Medicines Market report?

Ans: The main players in the Diagnostic Nuclear Medicines Market are Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly

What are the Application segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Applications covered in the Diagnostic Nuclear Medicines Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Types covered in the Diagnostic Nuclear Medicines Market report are Tc-99m, F-18, Other

1 Diagnostic Nuclear Medicines Market Overview

1.1 Product Overview and Scope of Diagnostic Nuclear Medicines

1.2 Diagnostic Nuclear Medicines Segment by Type

1.2.1 Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024-2030)

1.2.2 Tc-99m

1.2.3 F-18

1.2.4 Other

1.3 Diagnostic Nuclear Medicines Segment by Application

1.3.1 Global Diagnostic Nuclear Medicines Market Value by Application: (2024-2030)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Diagnostic Nuclear Medicines Market Size Estimates and Forecasts

1.4.1 Global Diagnostic Nuclear Medicines Revenue 2019-2030

1.4.2 Global Diagnostic Nuclear Medicines Sales 2019-2030

1.4.3 Global Diagnostic Nuclear Medicines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Diagnostic Nuclear Medicines Market Competition by Manufacturers

2.1 Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Diagnostic Nuclear Medicines Average Price by Manufacturers (2019-2024)

2.4 Global Diagnostic Nuclear Medicines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Type & Application

2.7 Diagnostic Nuclear Medicines Market Competitive Situation and Trends

2.7.1 Diagnostic Nuclear Medicines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Nuclear Medicines Players Market Share by Revenue

2.7.3 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Diagnostic Nuclear Medicines Retrospective Market Scenario by Region

3.1 Global Diagnostic Nuclear Medicines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Diagnostic Nuclear Medicines Global Diagnostic Nuclear Medicines Sales by Region: 2019-2030

3.2.1 Global Diagnostic Nuclear Medicines Sales by Region: 2019-2024

3.2.2 Global Diagnostic Nuclear Medicines Sales by Region: 2025-2030

3.3 Global Diagnostic Nuclear Medicines Global Diagnostic Nuclear Medicines Revenue by Region: 2019-2030

3.3.1 Global Diagnostic Nuclear Medicines Revenue by Region: 2019-2024

3.3.2 Global Diagnostic Nuclear Medicines Revenue by Region: 2025-2030

3.4 North America Diagnostic Nuclear Medicines Market Facts & Figures by Country

3.4.1 North America Diagnostic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Diagnostic Nuclear Medicines Sales by Country (2019-2030)

3.4.3 North America Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Country

3.5.1 Europe Diagnostic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Diagnostic Nuclear Medicines Sales by Country (2019-2030)

3.5.3 Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Country

3.6.1 Asia Pacific Diagnostic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Diagnostic Nuclear Medicines Sales by Country (2019-2030)

3.6.3 Asia Pacific Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Diagnostic Nuclear Medicines Market Facts & Figures by Country

3.7.1 Latin America Diagnostic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2030)

3.7.3 Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Country

3.8.1 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Diagnostic Nuclear Medicines Sales by Type (2019-2030)

4.1.1 Global Diagnostic Nuclear Medicines Sales by Type (2019-2024)

4.1.2 Global Diagnostic Nuclear Medicines Sales by Type (2025-2030)

4.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

4.2 Global Diagnostic Nuclear Medicines Revenue by Type (2019-2030)

4.2.1 Global Diagnostic Nuclear Medicines Revenue by Type (2019-2024)

4.2.2 Global Diagnostic Nuclear Medicines Revenue by Type (2025-2030)

4.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

4.3 Global Diagnostic Nuclear Medicines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Diagnostic Nuclear Medicines Sales by Application (2019-2030)

5.1.1 Global Diagnostic Nuclear Medicines Sales by Application (2019-2024)

5.1.2 Global Diagnostic Nuclear Medicines Sales by Application (2025-2030)

5.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

5.2 Global Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

5.2.1 Global Diagnostic Nuclear Medicines Revenue by Application (2019-2024)

5.2.2 Global Diagnostic Nuclear Medicines Revenue by Application (2025-2030)

5.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

5.3 Global Diagnostic Nuclear Medicines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Cardinal Health

6.1.1 Cardinal Health Corporation Information

6.1.2 Cardinal Health Description and Business Overview

6.1.3 Cardinal Health Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Cardinal Health Diagnostic Nuclear Medicines Product Portfolio

6.1.5 Cardinal Health Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Corporation Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GE Healthcare Diagnostic Nuclear Medicines Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Curium Pharma

6.3.1 Curium Pharma Corporation Information

6.3.2 Curium Pharma Description and Business Overview

6.3.3 Curium Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Curium Pharma Diagnostic Nuclear Medicines Product Portfolio

6.3.5 Curium Pharma Recent Developments/Updates

6.4 Jubilant Pharma

6.4.1 Jubilant Pharma Corporation Information

6.4.2 Jubilant Pharma Description and Business Overview

6.4.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio

6.4.5 Jubilant Pharma Recent Developments/Updates

6.5 Bracco Imaging

6.5.1 Bracco Imaging Corporation Information

6.5.2 Bracco Imaging Description and Business Overview

6.5.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio

6.5.5 Bracco Imaging Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novartis Diagnostic Nuclear Medicines Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 SIEMENS

6.6.1 SIEMENS Corporation Information

6.6.2 SIEMENS Description and Business Overview

6.6.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 SIEMENS Diagnostic Nuclear Medicines Product Portfolio

6.7.5 SIEMENS Recent Developments/Updates

6.8 China Isotope & Radiation

6.8.1 China Isotope & Radiation Corporation Information

6.8.2 China Isotope & Radiation Description and Business Overview

6.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio

6.8.5 China Isotope & Radiation Recent Developments/Updates

6.9 Dongcheng

6.9.1 Dongcheng Corporation Information

6.9.2 Dongcheng Description and Business Overview

6.9.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Dongcheng Diagnostic Nuclear Medicines Product Portfolio

6.9.5 Dongcheng Recent Developments/Updates

6.10 Lantheus

6.10.1 Lantheus Corporation Information

6.10.2 Lantheus Description and Business Overview

6.10.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Lantheus Diagnostic Nuclear Medicines Product Portfolio

6.10.5 Lantheus Recent Developments/Updates

6.11 Eli Lilly

6.11.1 Eli Lilly Corporation Information

6.11.2 Eli Lilly Diagnostic Nuclear Medicines Description and Business Overview

6.11.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Eli Lilly Diagnostic Nuclear Medicines Product Portfolio

6.11.5 Eli Lilly Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Diagnostic Nuclear Medicines Industry Chain Analysis

7.2 Diagnostic Nuclear Medicines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Diagnostic Nuclear Medicines Production Mode & Process

7.4 Diagnostic Nuclear Medicines Sales and Marketing

7.4.1 Diagnostic Nuclear Medicines Sales Channels

7.4.2 Diagnostic Nuclear Medicines Distributors

7.5 Diagnostic Nuclear Medicines Customers

8 Diagnostic Nuclear Medicines Market Dynamics

8.1 Diagnostic Nuclear Medicines Industry Trends

8.2 Diagnostic Nuclear Medicines Market Drivers

8.3 Diagnostic Nuclear Medicines Market Challenges

8.4 Diagnostic Nuclear Medicines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bracco Imaging

Lantheus

GE Healthcare

China Isotope & Radiation

List of Tables

Table 1. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Diagnostic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Diagnostic Nuclear Medicines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Diagnostic Nuclear Medicines Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Diagnostic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Type & Application

Table 12. Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 18. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2024)

Table 19. Global Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 20. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2025-2030)

Table 21. Global Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2024)

Table 23. Global Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2025-2030)

Table 25. North America Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 27. North America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 28. North America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 32. Europe Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 33. Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2019-2024)

Table 51. Global Diagnostic Nuclear Medicines Sales (K Units) by Type (2025-2030)

Table 52. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2024)

Table 53. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2025-2030)

Table 54. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2024)

Table 57. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2025-2030)

Table 58. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2019-2024)

Table 59. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2025-2030)

Table 60. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2019-2024)

Table 61. Global Diagnostic Nuclear Medicines Sales (K Units) by Application (2025-2030)

Table 62. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2024)

Table 63. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2025-2030)

Table 64. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Diagnostic Nuclear Medicines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2024)

Table 67. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2025-2030)

Table 68. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2019-2024)

Table 69. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2025-2030)

Table 70. Cardinal Health Corporation Information

Table 71. Cardinal Health Description and Business Overview

Table 72. Cardinal Health Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Cardinal Health Diagnostic Nuclear Medicines Product

Table 74. Cardinal Health Recent Developments/Updates

Table 75. GE Healthcare Corporation Information

Table 76. GE Healthcare Description and Business Overview

Table 77. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. GE Healthcare Diagnostic Nuclear Medicines Product

Table 79. GE Healthcare Recent Developments/Updates

Table 80. Curium Pharma Corporation Information

Table 81. Curium Pharma Description and Business Overview

Table 82. Curium Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Curium Pharma Diagnostic Nuclear Medicines Product

Table 84. Curium Pharma Recent Developments/Updates

Table 85. Jubilant Pharma Corporation Information

Table 86. Jubilant Pharma Description and Business Overview

Table 87. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Jubilant Pharma Diagnostic Nuclear Medicines Product

Table 89. Jubilant Pharma Recent Developments/Updates

Table 90. Bracco Imaging Corporation Information

Table 91. Bracco Imaging Description and Business Overview

Table 92. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Bracco Imaging Diagnostic Nuclear Medicines Product

Table 94. Bracco Imaging Recent Developments/Updates

Table 95. Novartis Corporation Information

Table 96. Novartis Description and Business Overview

Table 97. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Novartis Diagnostic Nuclear Medicines Product

Table 99. Novartis Recent Developments/Updates

Table 100. SIEMENS Corporation Information

Table 101. SIEMENS Description and Business Overview

Table 102. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. SIEMENS Diagnostic Nuclear Medicines Product

Table 104. SIEMENS Recent Developments/Updates

Table 105. China Isotope & Radiation Corporation Information

Table 106. China Isotope & Radiation Description and Business Overview

Table 107. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. China Isotope & Radiation Diagnostic Nuclear Medicines Product

Table 109. China Isotope & Radiation Recent Developments/Updates

Table 110. Dongcheng Corporation Information

Table 111. Dongcheng Description and Business Overview

Table 112. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Dongcheng Diagnostic Nuclear Medicines Product

Table 114. Dongcheng Recent Developments/Updates

Table 115. Lantheus Corporation Information

Table 116. Lantheus Description and Business Overview

Table 117. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Lantheus Diagnostic Nuclear Medicines Product

Table 119. Lantheus Recent Developments/Updates

Table 120. Eli Lilly Corporation Information

Table 121. Eli Lilly Description and Business Overview

Table 122. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Eli Lilly Diagnostic Nuclear Medicines Product

Table 124. Eli Lilly Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Diagnostic Nuclear Medicines Distributors List

Table 128. Diagnostic Nuclear Medicines Customers List

Table 129. Diagnostic Nuclear Medicines Market Trends

Table 130. Diagnostic Nuclear Medicines Market Drivers

Table 131. Diagnostic Nuclear Medicines Market Challenges

Table 132. Diagnostic Nuclear Medicines Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Diagnostic Nuclear Medicines

Figure 2. Global Diagnostic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type in 2023 & 2030

Figure 4. Tc-99m Product Picture

Figure 5. F-18 Product Picture

Figure 6. Other Product Picture

Figure 7. Global Diagnostic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Diagnostic Nuclear Medicines Market Share by Application in 2023 & 2030

Figure 9. Oncology

Figure 10. Cardiology

Figure 11. Other

Figure 12. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Diagnostic Nuclear Medicines Market Size (2019-2030) & (US$ Million)

Figure 14. Global Diagnostic Nuclear Medicines Sales (2019-2030) & (K Units)

Figure 15. Global Diagnostic Nuclear Medicines Average Price (USD/Unit) & (2019-2030)

Figure 16. Diagnostic Nuclear Medicines Report Years Considered

Figure 17. Diagnostic Nuclear Medicines Sales Share by Manufacturers in 2023

Figure 18. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Diagnostic Nuclear Medicines Players: Market Share by Revenue in 2023

Figure 20. Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)

Figure 23. North America Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)

Figure 27. Europe Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)

Figure 28. Germany Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2030)

Figure 35. China Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)

Figure 46. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Diagnostic Nuclear Medicines Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Diagnostic Nuclear Medicines Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Diagnostic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Diagnostic Nuclear Medicines by Type (2019-2030)

Figure 56. Global Revenue Market Share of Diagnostic Nuclear Medicines by Type (2019-2030)

Figure 57. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Diagnostic Nuclear Medicines by Application (2019-2030)

Figure 59. Global Revenue Market Share of Diagnostic Nuclear Medicines by Application (2019-2030)

Figure 60. Global Diagnostic Nuclear Medicines Price (USD/Unit) by Application (2019-2030)

Figure 61. Diagnostic Nuclear Medicines Value Chain

Figure 62. Diagnostic Nuclear Medicines Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions